Importantly, the depletion of neutrophils hampered the tumoricidal effect of CpG-B treatment, leading to loss in DC activation/maturation and a reduced number of CD8+ T cells in tumor tissue and tumor-draining lymph nodes. The gene discussed is CD8A; the disease is neoplasm.